Medications

Ozanimod beats placebo for ulcerative colitis

(HealthDay)—For patients with moderately to severely active ulcerative colitis, ozanimod is more effective than placebo as induction and maintenance therapy, according to a study published in the Sept. 30 issue of the New ...

Medications

Drug boosts survival for women with advanced ovarian cancer

Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer ...

Diseases, Conditions, Syndromes

French virus tracing app flops with only 14 alerts

France's much-heralded new phone app for tracking coronavirus cases has only alerted 14 people that they were at risk of infection since its launch three weeks ago, the digital affairs minister said Tuesday.

Medical research

New study challenges our understanding of premature ageing

Disturbances in the function of mitochondrial DNA can accelerate the ageing process in ways that are different than previously thought, according to a new Finnish study published in Nature Metabolism. Offering a new perspective ...

page 2 from 7